DK219084D0 - Antigen - Google Patents

Antigen

Info

Publication number
DK219084D0
DK219084D0 DK2190/84A DK219084A DK219084D0 DK 219084 D0 DK219084 D0 DK 219084D0 DK 2190/84 A DK2190/84 A DK 2190/84A DK 219084 A DK219084 A DK 219084A DK 219084 D0 DK219084 D0 DK 219084D0
Authority
DK
Denmark
Prior art keywords
antigen
adhesin
determinant
antibodies against
immunogenically active
Prior art date
Application number
DK2190/84A
Other languages
Danish (da)
English (en)
Inventor
Frederik Carl Peter Lindberg
Bjoern Olof Lund
Britt Monika Baaga
Mari Elisabet Norgren
Mikael Goeransson
Bernt Erik Anund Uhlin
Jan Staffan Normark
Original Assignee
Frederik Carl Peter Lindberg
Bjoern Olof Lund
Britt Monika Baaga
Mari Elisabet Norgren
Mikael Goeransson
Bernt Erik Anund Uhlin
Jan Staffan Normark
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frederik Carl Peter Lindberg, Bjoern Olof Lund, Britt Monika Baaga, Mari Elisabet Norgren, Mikael Goeransson, Bernt Erik Anund Uhlin, Jan Staffan Normark filed Critical Frederik Carl Peter Lindberg
Priority to DK2190/84A priority Critical patent/DK219084D0/da
Publication of DK219084D0 publication Critical patent/DK219084D0/da
Priority to AT85902487T priority patent/ATE91629T1/de
Priority to JP60502188A priority patent/JP2974028B2/ja
Priority to IE110285A priority patent/IE59826B1/en
Priority to CA000480663A priority patent/CA1340847C/en
Priority to KR1019850700417A priority patent/KR950000688B1/ko
Priority to US06/817,849 priority patent/US4795803A/en
Priority to AU42994/85A priority patent/AU593770B2/en
Priority to DE85902487T priority patent/DE3587468T2/de
Priority to EP85902487A priority patent/EP0179887B1/de
Priority to PCT/DK1985/000045 priority patent/WO1985005037A1/en
Priority to DK609985A priority patent/DK171258B1/da
Priority to SU864001551A priority patent/RU1787165C/ru
Priority to FI860015A priority patent/FI93310C/fi
Priority to US08/447,685 priority patent/US5804198A/en
Priority to JP8162018A priority patent/JPH09183791A/ja
Priority to US09/075,396 priority patent/US6291649B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/82—Subcellular parts of microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
DK2190/84A 1984-02-02 1984-05-02 Antigen DK219084D0 (da)

Priority Applications (17)

Application Number Priority Date Filing Date Title
DK2190/84A DK219084D0 (da) 1984-05-02 1984-05-02 Antigen
PCT/DK1985/000045 WO1985005037A1 (en) 1984-05-02 1985-05-02 Adhesin antigens, antibodies and dna fragment encoding the antigen, methods and means for diagnosis and immunization etc.
US06/817,849 US4795803A (en) 1984-05-02 1985-05-02 Adhesin antigens, antibodies and DNA fragment encoding the antigen, methods and means for diagnosis and immunization etc.
DE85902487T DE3587468T2 (de) 1984-05-02 1985-05-02 Adhesin-antigene, antikörper und dns-fragmente die das antigen kodieren, verfahren und mittel zur diagnose und immunisierung, usw.
IE110285A IE59826B1 (en) 1984-05-02 1985-05-02 Adhesin antigens, antibodies and dna fragment encoding the entigen, methods and means for diagnosis and immunization etc.
CA000480663A CA1340847C (en) 1984-02-02 1985-05-02 Adhesin antigens
KR1019850700417A KR950000688B1 (ko) 1984-05-02 1985-05-02 어드히진(Adhesin) 항원의 제조방법 및 그 항원에서 유도되는 항체의 제조방법
AT85902487T ATE91629T1 (de) 1984-05-02 1985-05-02 Adhesin-antigene, antikoerper und dns-fragmente die das antigen kodieren, verfahren und mittel zur diagnose und immunisierung, usw.
AU42994/85A AU593770B2 (en) 1984-05-02 1985-05-02 Adhesin antigens, antibodies and DNA fragment encoding the antigen, methods and means for diagnosis and immunization etc
JP60502188A JP2974028B2 (ja) 1984-05-02 1985-05-02 アドヒシン抗原類
EP85902487A EP0179887B1 (de) 1984-05-02 1985-05-02 Adhesin-antigene, antikörper und dns-fragmente die das antigen kodieren, verfahren und mittel zur diagnose und immunisierung, usw.
DK609985A DK171258B1 (da) 1984-05-02 1985-12-30 Antigent præparat indeholdende en determinant fra et adhesin-polypeptid, fremgangsmåder til fremstilling af deteminanten og adhesin-polypeptidet, anvendelser af determinanten og adhesin-polypeptidet, vaccine indeholdende determinanten, fremgangsmåde til fremstilling af vaccinen, antistof rettet mod determinanten, fremgangsmåde til fremstilling af antistoffet, præparatet til passiv immunisering
SU864001551A RU1787165C (ru) 1984-05-02 1986-01-02 Способ получени антигенного препарата, обладающего адгезивными свойствами, из фимбрий
FI860015A FI93310C (fi) 1984-05-02 1986-01-02 Menetelmä rokotteen valmistamiseksi piluksia kantavien nisäkkään kudoksiin tarttuvien bakteerien aiheuttamia tauteja vastaan
US08/447,685 US5804198A (en) 1984-05-02 1995-05-23 Vaccines against disease caused by pathogenic pilus-forming bacteria
JP8162018A JPH09183791A (ja) 1984-05-02 1996-06-21 Ｄｎａ断片
US09/075,396 US6291649B1 (en) 1984-05-02 1998-05-11 Anti-bodies binding adhesin-derived antigens

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK2190/84A DK219084D0 (da) 1984-05-02 1984-05-02 Antigen

Publications (1)

Publication Number Publication Date
DK219084D0 true DK219084D0 (da) 1984-05-02

Family

ID=8110676

Family Applications (2)

Application Number Title Priority Date Filing Date
DK2190/84A DK219084D0 (da) 1984-02-02 1984-05-02 Antigen
DK609985A DK171258B1 (da) 1984-05-02 1985-12-30 Antigent præparat indeholdende en determinant fra et adhesin-polypeptid, fremgangsmåder til fremstilling af deteminanten og adhesin-polypeptidet, anvendelser af determinanten og adhesin-polypeptidet, vaccine indeholdende determinanten, fremgangsmåde til fremstilling af vaccinen, antistof rettet mod determinanten, fremgangsmåde til fremstilling af antistoffet, præparatet til passiv immunisering

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK609985A DK171258B1 (da) 1984-05-02 1985-12-30 Antigent præparat indeholdende en determinant fra et adhesin-polypeptid, fremgangsmåder til fremstilling af deteminanten og adhesin-polypeptidet, anvendelser af determinanten og adhesin-polypeptidet, vaccine indeholdende determinanten, fremgangsmåde til fremstilling af vaccinen, antistof rettet mod determinanten, fremgangsmåde til fremstilling af antistoffet, præparatet til passiv immunisering

Country Status (13)

Country Link
US (3) US4795803A (de)
EP (1) EP0179887B1 (de)
JP (2) JP2974028B2 (de)
KR (1) KR950000688B1 (de)
AT (1) ATE91629T1 (de)
AU (1) AU593770B2 (de)
CA (1) CA1340847C (de)
DE (1) DE3587468T2 (de)
DK (2) DK219084D0 (de)
FI (1) FI93310C (de)
IE (1) IE59826B1 (de)
RU (1) RU1787165C (de)
WO (1) WO1985005037A1 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4736017A (en) * 1984-04-30 1988-04-05 The Board Of Trustees Of The Leland Stanford Junior University Chemically defined vaccine against urinary infections
US4584195A (en) * 1984-06-21 1986-04-22 The Board Of Trustees Of The Leland Stanford Junior University Broad spectrum vaccine against gonorrhea
US4740585A (en) * 1984-07-30 1988-04-26 The Board Of Trustees Of The Leland Stanford Junior University Synthetic vaccine against urinary infections
US5288617A (en) * 1984-10-31 1994-02-22 Commonwealth Scientific And Industrial Research Organization Method of producing an antigenic preparation
ZA858374B (en) * 1984-10-31 1986-07-30 Commw Scient Ind Res Org Antigenic preparation
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
DE3689713T2 (de) * 1985-08-01 1994-07-07 Miles Inc Schützende Antikörper gegen serotypische Determinanten von flagellären Antigenen.
US4900659A (en) * 1986-01-30 1990-02-13 Enzo Biochem, Inc. Nucleotide sequence composition and method for detection of Neisseria gonorrhoeae and method for screening for a nucleotide sequence that is specific for a genetically distinct group
US4801690A (en) * 1986-03-24 1989-01-31 Bactex, Inc. Novel lectins derived from bacterial pili
SE8601940D0 (sv) * 1986-04-25 1986-04-25 Kabigen Ab Preparation of fused proteins, antibodies and processes therefor
US4786592A (en) * 1986-06-18 1988-11-22 Scripps Clinic And Research Foundation Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin
US7087742B1 (en) 1986-11-24 2006-08-08 Gen-Probe Incorporated Oligonucleotide probes for the detection and/or quantitation of non-viral organisms
US7090972B1 (en) 1986-11-24 2006-08-15 Gen-Probe Incorporated Methods for determining the presence of non-viral organisms in a sample
US5036003A (en) * 1987-08-21 1991-07-30 Monsanto Company Antibodies to VPF
AU601510B2 (en) * 1987-11-06 1990-09-13 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
SE8801894D0 (sv) * 1988-05-20 1988-05-20 Alfa Laval Agri Int Fibronektinbindande protein
US5055455A (en) * 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
US7172863B1 (en) 1988-12-09 2007-02-06 Gen-Probe Incorporated Nucleic acid probes and methods for detecting Neisseria gonorrhoeae
CA1340530C (en) * 1989-04-28 1999-05-04 Kok Kheong Lee Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
SE8901687D0 (sv) * 1989-05-11 1989-05-11 Alfa Laval Agri Int Fibronectin binding protein as well as its preparation
US5202113A (en) * 1990-04-30 1993-04-13 The United States Of America As Represented By The Department Of Health And Human Services Plaque-inhibiting protein from bacteroides loeschei and methods for using the same
ATE173827T1 (de) * 1990-08-02 1998-12-15 Antex Biolog Inc Adhäsionsrezeptoren für pathogene oder opportunistische mikroorganismen
US5440014A (en) * 1990-08-10 1995-08-08 H+E,Uml/Oo/ K; Magnus Fibronectin binding peptide
JPH06504670A (ja) * 1990-12-21 1994-06-02 マイクロカーブ　インコーポレイティド 微生物に関する脂質レセプター及び対応の付着因子、付着因子をコードするｄｎａ配列、並びにそれらの利用方法
US5843463A (en) * 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
US5834591A (en) * 1991-01-31 1998-11-10 Washington University Polypeptides and antibodies useful for the diagnosis and treatment of pathogenic neisseria and other microorganisms having type 4 pilin
US5980908A (en) * 1991-12-05 1999-11-09 Alfa Laval Ab Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
AU662783B2 (en) 1992-01-08 1995-09-14 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezonheid En Cultuur Whooping cough vaccine
ES2185658T3 (es) * 1993-05-18 2003-05-01 Univ Ohio State Res Found Vacuna para la otitis media.
US5648240A (en) * 1994-05-24 1997-07-15 Texas A&M University MHC II analog from Staphylococcus aureus
WO1996000233A1 (en) * 1994-06-24 1996-01-04 Children's Hospital And Medical Center Escherichia coli o157:h7 epithelial adhesin
DE19534579C2 (de) * 1995-09-18 2000-06-08 Max Planck Gesellschaft Nucleinsäure-Moleküle codierend Proteine, die die Adhäsion von Neisseria-Zellen an humane Zellen vermitteln
US6872398B2 (en) * 1995-12-22 2005-03-29 The United States Of America As Represented By The Secretary Of The Army Conjugate vaccine against gram-negative bacterial infections
CA2257826C (en) * 1996-06-10 2011-11-22 Thomas Boren Helicobacter pylori adhesin binding group antigen
AU1979599A (en) * 1998-01-14 1999-08-02 Chiron S.P.A. (neisseria meningitidis) antigens
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
EP1121149A4 (de) * 1998-08-31 2002-03-20 Inhibitex Inc Immunotherapeutika gegen staphylokokkus mittels donor selektion und donor stimulation
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US20040001863A1 (en) * 1998-12-03 2004-01-01 Shau-Chi Chi Immortal cell line derived from grouper Epinephelus coioides and its applications therein
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
NZ519655A (en) * 1999-12-21 2004-04-30 Merial Sas Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen
DK1328543T3 (da) * 2000-10-27 2009-11-23 Novartis Vaccines & Diagnostic Nukleinsyrer og proteiner fra streptococcus-gruppe A & B
PT1377314E (pt) 2001-01-26 2012-01-02 Inhibitex Inc Anticorpos monoclonais para a proteína clfa e método de utilização no tratamento ou prevenção de infecções
US20030194798A1 (en) 2001-05-24 2003-10-16 Surber Mark W. Minicell compositions and methods
US7396822B2 (en) * 2001-05-24 2008-07-08 Vaxiion Therapeutics, Inc. Immunogenic minicells and methods of use
US7132101B2 (en) * 2002-02-27 2006-11-07 Duquesne University Of The Holy Ghost Compositions and methods for eliciting an immune response to gram-negative bacterial infections
US20040067544A1 (en) * 2002-06-27 2004-04-08 Viola Vogel Use of adhesion molecules as bond stress-enhanced nanoscale binding switches
AU2003290867A1 (en) * 2002-11-12 2004-06-03 The Brigham And Women's Hospital, Inc. Methods and products for treating staphylococcal infections
WO2004043405A2 (en) 2002-11-12 2004-05-27 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
WO2006055024A2 (en) * 2004-04-05 2006-05-26 Vaxiion Therapeutics, Inc. Minicells as vaccines
AU2005236068C1 (en) 2004-04-21 2012-08-30 Beth Israel Deaconess Medical Center, Inc. Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof
US8251846B2 (en) * 2006-08-02 2012-08-28 Wilson Sporting Goods Co. Game ball having optimally positioned grooves
US7585236B2 (en) * 2006-08-02 2009-09-08 Wilson Sporting Goods Co. Game ball having optimally positioned grooves and/or ridges
US7686713B2 (en) * 2007-04-11 2010-03-30 Wilson Sporting Goods Co. Racquet stringing machine
WO2009014782A2 (en) * 2007-04-27 2009-01-29 Dow Global Technologies Inc. Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
KR20110031393A (ko) 2008-07-21 2011-03-25 더 브리검 앤드 우먼즈 하스피털, 인크. 합성 베타-1,6 글루코사민 올리고당에 관한 방법 및 조성물
ES2720659T3 (es) 2011-02-15 2019-07-23 Vaxiion Therapeutics Llc Composiciones terapéuticas y métodos para la administración dirigida, mediante minicélulas bacterianas, de moléculas bioactivas basadas en moléculas dirigidas que contienen Fc y anticuerpos
WO2020163512A1 (en) 2019-02-05 2020-08-13 The Brigham And Women's Hospital, Inc. Polysaccharide compositions for use in treating filariasis

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472624A (en) * 1974-09-02 1977-05-04 Canadian Patents Dev Enteric disease vaccine
AU509621B2 (en) * 1975-04-25 1980-05-22 Dactex, Inc Detection, and'Prevention of Diseases caused by N, Gonorrhoeae
US4461838A (en) * 1975-04-25 1984-07-24 Bactex, Inc. Gonococcal Pili processes for the preparation thereof and the use thereof for the detection of and prevention of infections caused by Neisseria gonorrhoeae
GB1553664A (en) * 1975-06-12 1979-09-26 Unilever Ltd Antigenic compositions
US4136167A (en) * 1975-06-12 1979-01-23 Internationale Octrooi Maatschappij "Octropa" B.V. Process for reducing the incidence of neonatal diarrhoea in pigs
US4237115A (en) * 1977-11-23 1980-12-02 Bactex, Inc. Method of immunization against enterotoxogenic infection by Escherichia coli
US4336336A (en) * 1979-01-12 1982-06-22 President And Fellows Of Harvard College Fused gene and method of making and using same
FR2466251B1 (fr) * 1979-10-03 1983-03-18 Agronomique Inst Nat Rech Vaccin animal anticolibacillaire, obtention et application
US4311797A (en) * 1979-09-18 1982-01-19 University Of Saskatchewan Anucleated live E. coli vaccine
SE8001748L (sv) * 1980-03-05 1981-09-06 Kaellenius Gunilla Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
US4454117A (en) * 1980-09-15 1984-06-12 Bactex, Inc. Immunization against infection by Escherichia coli
GB2094314A (en) * 1981-02-05 1982-09-15 Wellcome Found Recombinant DNA
NZ199866A (en) * 1981-03-09 1984-11-09 Cetus Corp Vaccine for prevention of gastroenteric disease:non-pathogenic strain genetically engineered to comprise genes for adhesin and/or toxoids
US4443431A (en) * 1981-05-27 1984-04-17 The United States Of America As Represented By The Department Of Health And Human Services Neisseria gonorrhoeae vaccine
AU560262B2 (en) * 1981-10-19 1987-04-02 Molecular Genetics, Inc. Antibodies derived from hybrid line from (myeloma + antibody producing cell)
US4443549A (en) * 1981-10-19 1984-04-17 Molecular Genetics, Inc. Production of monoclonal antibodies against bacterial adhesins
FR2516385A1 (fr) * 1981-11-19 1983-05-20 Merieux Inst Vaccin anti-aphteux et anti-colibacillaire et son procede de preparation
WO1983002456A2 (fr) * 1982-01-18 1983-07-21 Ceska, Miroslav Nouveaux plasmides et souches de bacteries et leur procede de fabrication
DK131083A (da) * 1982-03-23 1983-09-24 Svenska Sockerfabriks Ab Fremgangsmaade til fremstilling af terapeutiske eller diagnostiske praeparater
US4521334A (en) * 1982-07-27 1985-06-04 The University Of Tennesse Research Corporation Synthetic polypeptide fragments
US4597967A (en) * 1982-07-27 1986-07-01 The University Of Tennessee Research Corp. Synthetic polypeptide fragments
NZ205392A (en) * 1982-09-02 1987-03-06 Unilever Plc Preparation of immunoglobulins against e.coli pili
US4652448A (en) * 1982-10-07 1987-03-24 Molecular Genetics, Inc. Use of monoclonal antibodies against bacterial adhesins
US4736017A (en) * 1984-04-30 1988-04-05 The Board Of Trustees Of The Leland Stanford Junior University Chemically defined vaccine against urinary infections
US4801690A (en) * 1986-03-24 1989-01-31 Bactex, Inc. Novel lectins derived from bacterial pili
US4786592A (en) * 1986-06-18 1988-11-22 Scripps Clinic And Research Foundation Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin

Also Published As

Publication number Publication date
DE3587468D1 (de) 1993-08-26
ATE91629T1 (de) 1993-08-15
DK609985D0 (da) 1985-12-30
AU593770B2 (en) 1990-02-22
KR860700090A (ko) 1986-03-31
EP0179887B1 (de) 1993-07-21
DK171258B1 (da) 1996-08-12
DK609985A (da) 1985-12-30
US6291649B1 (en) 2001-09-18
US4795803A (en) 1989-01-03
JPH09183791A (ja) 1997-07-15
IE59826B1 (en) 1994-04-06
JPS62501355A (ja) 1987-06-04
AU4299485A (en) 1985-11-28
FI93310B (fi) 1994-12-15
FI860015L (fi) 1986-01-02
FI860015A0 (fi) 1986-01-02
US5804198A (en) 1998-09-08
RU1787165C (ru) 1993-01-07
FI93310C (fi) 1995-03-27
DE3587468T2 (de) 1993-12-02
IE851102L (en) 1985-11-02
CA1340847C (en) 1999-12-14
EP0179887A1 (de) 1986-05-07
KR950000688B1 (ko) 1995-01-27
JP2974028B2 (ja) 1999-11-08
WO1985005037A1 (en) 1985-11-21

Similar Documents

Publication Publication Date Title
DK219084D0 (da) Antigen
DK0626447T3 (da) Monoklonale antistoffer og Fv, som er specifikke for CD2-antigen
PT86792A (pt) Monoclonal antibodies against melanoma-associated antigens hybrid cell lines producing these antibodies and use therefor
PT85995A (en) Process for preparing a chimeric antibody with specifity to human tumor antigen
EP0434713A4 (en) Hiv-1 envelope muteins lacking hypervariable domains
ES2124250T3 (es) Anticuerpo especifico para un antigeno tumoral.
ATE197068T1 (de) Toxoplasma gondii-antigene, ihre herstellung und ihre verwendung
ATE7855T1 (de) Herstellung von virusantigenen.
EP0111389A3 (de) Wesentlich sauberes Schweinewachstumshormon, DNS-Sequenzen dafür und Expressionsvektoren und transfektierte Mikroorganismen zur Herstellung von Schweinewachstumshormon
DK341679A (da) Vaccine mod streptokokker og fremgangsmaade til fremstilling deraf
ATE62253T1 (de) Menschlicher, monoklonaler antikoerper und seine herstellung.
ATE103989T1 (de) Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung.
EP0338395A3 (en) Monoclonal antibodies to pseudomonas aeruginosa, their production and use
KR850006705A (ko) 항파상풍항체 생산 인체-인체 하이브리도마의 제조방법
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
KR890002402A (ko) 인간의 유두종바이러스형 41, 이의 dna 및 이로부터 코드화된 단백질
GB1378103A (en) Serological reagent and test for neisseria gonorrhoeae antibodies
AU7144787A (en) Tumor-associated antigen (mol wt 68,000-48000; 40,000-80000; 28000-32000; 16000-19000)
ATE470700T1 (de) Bazillus zelle für die herstellung von proteinen
FI873489A0 (fi) Foerfarande foer framstaellning av 4-androsten-3,17-dion och 1,4-androstadien-3,17-dion.
KR870006190A (ko) 생리 활성 물질의 제조방법
KR950031110A (ko) 인간 혈증 아포지단백질 비-100(b-100)에 대한 신규 단일클론 항체 및 이들의 생산을 위한 재조합 하이브리도마 세포주
SU1398393A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus, используемый для получения моноклональных антител к микобактериям туберкулеза
KR960006941A (ko) 인간 혈중 아포지단백질(apolipoprotein) A-I에 대한 신규 단일클론 항체 및 이들의 생산을 위한 재조합 하이브리도마 세포주
KR880001825A (ko) 발효에 의한 5'-구아닐산의 제조방법

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment